Infectious Complications of Portal Hypertension.
Acute Decompensation
Acute-on-chronic liver failure
Clinically significant portal hypertension
Liver cirrhosis
Liver transplantation
Sepsis
Septic shock
Journal
Clinics in liver disease
ISSN: 1557-8224
Titre abrégé: Clin Liver Dis
Pays: United States
ID NLM: 9710002
Informations de publication
Date de publication:
Aug 2024
Aug 2024
Historique:
medline:
1
7
2024
pubmed:
1
7
2024
entrez:
30
6
2024
Statut:
ppublish
Résumé
Patients with cirrhosis and clinically significant portal hypertension are at high risk of developing bacterial infections (BIs) that are the most common trigger of acute decompensation and acute-on-chronic liver failure. Furthermore, after decompensation, the risk of developing BIs further increases in an ominous vicious circle. BIs may be subtle, and they should be ruled out in all patients at admission and in case of deterioration. Timely administration of adequate empirical antibiotics is the cornerstone of treatment. Herein, we reviewed current evidences about pathogenesis, clinical implications and management of BIs in patients with cirrhosis and portal hypertension.
Identifiants
pubmed: 38945641
pii: S1089-3261(24)00030-8
doi: 10.1016/j.cld.2024.03.007
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
525-539Informations de copyright
Copyright © 2024 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure PA held a patent with Biovie, received advisory board fees from Biovie, Biomarin, and GenFit and speaking fees from Grifols, Kedrion, and Bhering. SP received consulting fees from Plasma Protein Therapeutics Association and speaking fees from Grifols and Medscape. SI has nothing to disclose regarding the work under consideration for publication. No specific funding supported this study. Authors’ contribution: S. Incicco, P. Angeli, and S. Piano reviewed the literature and drafted the article.